ImmunityBio Presents Favorable Comparative Effectiveness Data in Complete Response Rates of NAI + BCG Versus Nadofaragene and TAR-200 at AUA 2026

Go back to ImmunityBio Presents Favorable Comparative Effectiveness Data in Complete Response Rates of NAI + BCG Versus Nadofaragene and TAR-200 at AUA 2026
(NASDAQ: IBRX) Delayed: 7.45 +0.23 (3.19%)
Previous Close $7.22    52 Week High
Open $7.05    52 Week Low
Day High $7.54    P/E N/A 
Day Low $7.00    EPS
Volume 5,698,882